Source: Contract Pharma

InSymbiosis: Camargo to Acquire InSymbiosis

Acquisition aims to improve how biopharma companies outsource R&D

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
CEO Avatar

President & CEO

Dean Wenham

CEO Approval Rating

90/100

Read more